• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.

作者信息

Haagensen D E, Stewart P, Dilley W G, Wells S A

机构信息

Department of Surgery, Methodist Hospital, Sacramento, California.

出版信息

Breast Cancer Res Treat. 1992;23(1-2):77-86. doi: 10.1007/BF01831479.

DOI:10.1007/BF01831479
PMID:1446056
Abstract

The effect of steroid hormones on modulating the secretion rates of three human breast gross cystic disease fluid proteins (GCDFP-15, GCDFP-24, and GCDFP-44) by T47D breast carcinoma cells in tissue culture was evaluated. Androgens (dihydrotestosterone or fluoxymesterone) were capable of stimulating the secretion rates for all three GCDFP's while showing a minimal trend toward slowing the growth rate of T47D cells. This is the first study which shows that androgens can specifically stimulate all three of the major breast GCDFP's concomitantly. Progesterone, and three synthetic progestins, all showed inhibition of the growth rate of T47D cells while causing enhancement of the secretion of GCDFP-15 and GCDFP-44, and only minimal effect on the secretion rate of GCDFP-24. Estradiol was essentially neutral to the growth rate of the T47D cells in our test system. Estradiol did cause a mild enhancement of GCDFP-44 secretion rate, with no appreciable effect on GCDFP-15 or GCDFP-24 secretion rates. These findings suggest that an androgenic stimulus may be involved in the secretion of GCDFP's associated with breast gross cystic disease.

摘要

相似文献

1
Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones.
Breast Cancer Res Treat. 1992;23(1-2):77-86. doi: 10.1007/BF01831479.
2
Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.雌激素和雄激素对人乳腺癌细胞中孕酮结合性乳腺囊肿蛋白GCDFP - 24分泌的调节:乳腺癌中类固醇作用的一种新标志物。
Endocrinology. 1990 Jun;126(6):3223-31. doi: 10.1210/endo-126-6-3223.
3
Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1 alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells.白细胞介素-6抑制雄激素、糖皮质激素和白细胞介素-1α对人乳腺癌细胞中载脂蛋白D和GCDFP-15表达的强效刺激作用。
Int J Cancer. 1995 Sep 15;62(6):732-7. doi: 10.1002/ijc.2910620614.
4
Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells.雌激素对ZR-75-1人乳腺癌细胞中GCDFP-15 mRNA水平及分泌的抑制作用。
Mol Endocrinol. 1989 Apr;3(4):694-702. doi: 10.1210/mend-3-4-694.
5
[Hormonal regulation of GCDFP-15 secretion in breast tumors. Study of cultured cells].[乳腺肿瘤中GCDFP-15分泌的激素调节。培养细胞研究]
Bull Cancer. 1989;76(8):805-11.
6
Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells.白细胞介素-4和白细胞介素-13可抑制雌激素诱导的乳腺癌细胞增殖,并刺激人乳腺癌细胞中GCDFP-15的表达。
Mol Cell Endocrinol. 1996 Jul 23;121(1):11-8. doi: 10.1016/0303-7207(96)03843-9.
7
Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer.雌激素与雄激素对ZR-75-1细胞中GCDFP-15基因表达的拮抗作用以及人乳腺癌中GCDFP-15与雌激素和孕激素受体表达之间的相关性。
J Steroid Biochem. 1989;34(1-6):397-402. doi: 10.1016/0022-4731(89)90115-5.
8
Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.15千道尔顿的乳腺囊肿病液体蛋白(GCDFP - 15)对乳腺癌细胞系和永生化乳腺细胞的促有丝分裂作用。
Int J Cancer. 1995 Jan 17;60(2):216-20. doi: 10.1002/ijc.2910600215.
9
Regulation of GCDFP-15 expression in human mammary cancer cells.人乳腺癌细胞中GCDFP - 15表达的调控
Int J Mol Med. 1999 Aug;4(2):135-40. doi: 10.3892/ijmm.4.2.135.
10
Opposite effects of estrogen and the progestin R5020 on cell proliferation and GCDFP-15 expression in ZR-75-1 human breast cancer cells.雌激素和孕激素R5020对ZR-75-1人乳腺癌细胞增殖和GCDFP-15表达的相反作用。
Mol Cell Endocrinol. 1990 Oct 22;73(2-3):171-8. doi: 10.1016/0303-7207(90)90130-z.

引用本文的文献

1
Association of Selected STAT Inhibitors with Prolactin-Induced Protein (PIP) in Breast Cancer.乳腺癌中所选信号转导和转录激活因子(STAT)抑制剂与催乳素诱导蛋白(PIP)的关联
Int J Mol Sci. 2025 Feb 7;26(4):1416. doi: 10.3390/ijms26041416.
2
Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer.催乳素诱导蛋白(PIP)在乳腺癌中的预后作用
Cells. 2023 Sep 11;12(18):2252. doi: 10.3390/cells12182252.
3
Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.催乳素诱导蛋白(PIP)——特性及其在乳腺癌进展中的作用

本文引用的文献

1
Steroid hormone accumulation in human breast cyst fluid.类固醇激素在人乳腺囊肿液中的积聚。
Cancer Res. 1981 Jan;41(1):105-7.
2
The presentation and progress of macroscopic breast cysts.肉眼可见的乳腺囊肿的表现及进展
Br J Surg. 1980 Sep;67(9):669-71. doi: 10.1002/bjs.1800670922.
3
Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D).雌激素可刺激人乳腺癌细胞系(T47D)的细胞增殖并诱导分泌蛋白。
Am J Cancer Res. 2018 Nov 1;8(11):2150-2164. eCollection 2018.
4
Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent manner.催乳素诱导蛋白(PIP)以雌激素非依赖的方式调节腔面A型乳腺癌细胞的增殖。
PLoS One. 2013 Jun 3;8(6):e62361. doi: 10.1371/journal.pone.0062361. Print 2014.
5
Increased JNK1 activity contributes to the upregulation of ApoD in the apocrine secretory gland cells from axillary osmidrosis.JNK1 活性的增加导致腋臭大汗腺细胞中 ApoD 的上调。
Mol Cell Biochem. 2011 Aug;354(1-2):311-6. doi: 10.1007/s11010-011-0830-5. Epub 2011 Apr 28.
6
Genetic background influences murine prostate gene expression: implications for cancer phenotypes.遗传背景影响小鼠前列腺基因表达:对癌症表型的影响。
Genome Biol. 2007;8(6):R117. doi: 10.1186/gb-2007-8-6-r117.
7
A strong association between body fat mass and protein profiles in nipple aspirate fluid of healthy premenopausal non-lactating women.健康绝经前非哺乳期女性乳头抽吸液中体脂量与蛋白质谱之间存在密切关联。
Breast Cancer Res Treat. 2007 Jul;104(1):57-66. doi: 10.1007/s10549-006-9388-4. Epub 2006 Sep 27.
8
Expression of the androgen receptor and an androgen-responsive protein, apolipoprotein D, in human breast cancer.雄激素受体及一种雄激素反应蛋白——载脂蛋白D在人类乳腺癌中的表达
Br J Cancer. 1996 Oct;74(8):1175-80. doi: 10.1038/bjc.1996.513.
9
Expression and prognostic significance of apolipoprotein D in breast cancer.载脂蛋白D在乳腺癌中的表达及预后意义
Am J Pathol. 1994 Feb;144(2):310-20.
10
Glucocorticoids and androgens up-regulate the Zn-alpha 2-glycoprotein messenger RNA in human breast cancer cells.糖皮质激素和雄激素上调人乳腺癌细胞中的锌α2糖蛋白信使核糖核酸。
Breast Cancer Res Treat. 1994;29(3):247-58. doi: 10.1007/BF00666478.
J Clin Endocrinol Metab. 1982 Aug;55(2):276-83. doi: 10.1210/jcem-55-2-276.
4
A general, fast, and sensitive micromethod for DNA determination application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells.一种适用于大鼠和小鼠肝脏、大鼠肝癌、人白细胞、鸡成纤维细胞及酵母细胞的通用、快速且灵敏的微量DNA测定方法。
Anal Biochem. 1981 Jan 1;110(1):165-70. doi: 10.1016/0003-2697(81)90130-5.
5
Risk of breast cancer in women with benign breast disease.患有良性乳腺疾病的女性患乳腺癌的风险。
J Natl Cancer Inst. 1980 Jul;65(1):13-20.
6
Structures and concentrations of fifteen different steroid sulfates in human breast cyst fluids.人乳腺囊肿液中15种不同甾体硫酸盐的结构与浓度
J Steroid Biochem. 1984 Oct;21(4):367-71. doi: 10.1016/0022-4731(84)90298-x.
7
Risk of breast cancer in women with history of benign disease of the breast.有乳腺良性疾病史的女性患乳腺癌的风险。
Br Med J (Clin Res Ed). 1984 Jan 28;288(6413):275-8. doi: 10.1136/bmj.288.6413.275.
8
Dual effects of the progestin R5020 on proteins released by the T47D human breast cancer cells.孕激素R5020对T47D人乳腺癌细胞释放的蛋白质的双重作用。
J Biol Chem. 1984 Jan 25;259(2):1231-8.
9
Androgen conjugates in human breast cyst fluids.人乳腺囊肿液中的雄激素结合物。
J Natl Cancer Inst. 1982 Nov;69(5):1055-8.
10
Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
Clin Oncol. 1981 Sep;7(3):213-9.